Figure 14

Effect of NAR and NAR-HNPs on (a) immobility time, (b) latency to immobility time on diabetic rats subjected to FST. Results are stated as mean ± SEM. avs normal group, bvs control STZ group, cvs STZ + NAR (50 mg/kg), dvs STZ + NAR-HNPs (50 mg/kg) at p < 0.05. NAR, naringenin; STZ, streptozotocin; NAR-HNPs, naringenin- loaded hybridized nanoparticles.